Selective Capture (Molecular Recognition) of Acidic Steroids by Dietary Resistant Protein and Modeling of Antitumor Foods
通过膳食抗性蛋白选择性捕获(分子识别)酸性类固醇和抗肿瘤食品建模
基本信息
- 批准号:13660132
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
An insoluble "high-molecular-weight fraction" centrifugally separable from Protin^R-digested soy protein isolate has been referred to as HMF, which has a high capacity to capture bile acids and to accerelate their fecal excretion. A significant correlation was observed for the fecal excretion of nitrogen, lipid and acidic or neutral steroid in HMF-fed rats. Therefor, the feces from HMF-fed rats were rinsed out in pH 7.4 phosphate buffer, 70% ethanol and 1% Triton-containing 8M urea, and the resulting insoluble residue was examined for its amino acid composition and bile acid-caturing capacity. The constituent amino acids were Leu > Ala > Val, Ile > Gly > Phe > Pro > Tyr > Ser > Glu etc. in order of molar ratio, being quite similar in pattern to those of the remnant after artificial digestion with mammalian digestive enzymes. The bile acid-capturing capacity turned out to be 14 μmol/g feces which was nearly compatible with the amount of bile acids extractable from powdered whole feces w … More ith 70% ethanol after washing with the phosphate buffer. Accordingly the HMF remnant as well as the insoluble feces should be called "soybean resistant protein" with due consideration for no more digestible characteristic. A comparison of bile acid-capturing capacity was made by equilibrium dialysis on litocholic acid (LCA), deoxycholic acid (DCA), chenodeoxycholic acid (CDCA), hyodeoxycholic acid (HDCA), taurodeoxycholic acid (TDCA), glycocheno-deoxycholic acid (GCDCA), ursodeoxycholic acid (UDCA) and cholic acid (CA). Consequently, soybean resistant protein had a high affinity for bile acids in order of LCA, DCA, CDCA >> HDCA > TDCA, GCDCA > UDCA, CA. Noteworthily there was a clear difference between DCA and CA in that respect. This difference was also ascertained from a pattern of uncompetitive inhibition by DCA in Eadie-Scatchard plot of bound CDCA against its corresponding bound/free ratio with the aid of ^<14>C-CDCA. When its bile acid-capturing capacity was compared with those of various resistant proteins prepared by artificial digestion from leguminous and cereal food proteins, any preparation was far inferior to soybean resistant protein in affinity for secondary bile acid. The majority of primary bile acids escaped from intestinal absorption undergo dehydroxylation by enteric bacteria and convert to secondary bile acids fairly risky as promorter for carcinogenesis. Taking into account such a high affinity of resistant proteins for secondary bile acids, their successive intake in ordinary eating habits contributes greatly to cancer prevention besides inprovement in lipidemia or cholesterolemia. Less
从蛋白质R消化的大豆分离蛋白中分离出的一种不溶的“高分子量组分”被称为HMF,它具有很高的捕获胆汁酸和加速其排泄量的能力。饲喂HMF的大鼠的粪便氮、脂和酸性或中性类固醇排泄量之间存在显著的相关性。为此,饲喂HMF的大鼠的粪便在pH 7.4的磷酸盐缓冲液、70%乙醇和1%含Triton的8M尿素中漂洗,并检测其氨基酸组成和胆汁酸摄取能力。组成氨基酸按摩尔比依次为Leu>、Ala&Gt、Val、Ile&Gt、Gly&Gt、Phe&Gt、Pro&Gt、Tyr&Gt、Ser&Gt、Glu等,与哺乳动物消化酶人工消化后的残留物在形态上十分相似。对胆汁酸的捕集能力为14μ摩尔/克粪便,与…从粉状全粪便中提取胆汁酸的量基本一致。用磷酸盐缓冲液洗涤后,超过70%的乙醇。因此,HMF残留物以及不溶性粪便应被称为“大豆抗性蛋白”,但不应考虑更易消化的特性。比较平衡透析法对胆汁酸(LCA)、脱氧胆酸(DCA)、鹅去氧胆酸(CDCA)、猪去氧胆酸(HDCA)、牛磺酸脱氧胆酸(TDCA)、甘氨酸脱氧胆酸(GCDCA)、熊去氧胆酸(UDCA)和胆酸(CA)的捕集能力。因此,大豆抗性蛋白对胆汁酸的亲和力大小顺序为:LCA、DCA、CDCA>;>;HDCA>;TDCA、GCDCA>、UDCA、CA。值得注意的是,DCA和CA在这方面有明显的区别。这种差异也是从结合的CDCA的Eadie-Scatchard图中DCA相对于其相应的结合/自由比借助于^<;14>;C-CDCA的非竞争性抑制模式而得到的。将其对胆汁酸的捕集能力与豆类和谷类食品蛋白人工消化制备的各种抗性蛋白进行比较,发现其对次生胆汁酸的亲和力远低于大豆抗性蛋白。大多数从肠道吸收中逃逸出来的初级胆汁酸会被肠道细菌进行脱羟基,并转化为次级胆汁酸,这对致癌具有相当大的风险。考虑到抗药性蛋白对次级胆汁酸的高度亲和力,在日常饮食习惯中连续摄入这些蛋白,除了改善血脂或胆固醇血症外,还有助于预防癌症。较少
项目成果
期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Saeki T et al.: "Effect of Cys mutation on taurocholic acid transport by mouse ileal and hepatic sodium-dependent bile acid transporters"Biosci. Biotech. Biochem.. 66. 467-470 (2002)
Saeki T 等人:“Cys 突变对小鼠回肠和肝钠依赖性胆汁酸转运蛋白转运牛磺胆酸的影响”Biosci。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
岩見公和: "レジスタントプロテインの機能性とその応用"ジャパンフードサイエンス. 40(12). 40-44 (2001)
Kimikazu Iwami:“抗性蛋白的功能及其应用”日本食品科学 40(12) (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
佐伯 徹 他4名: "Effects of Cys mutation on taurocholic acid transport by mouse ileal and hepatic sodium-dependent bile acid transporters"Biosci. Biotechnol. Biochem.. 66(印刷中). (2002)
Toru Saeki 等 4 人:“Cys 突变对小鼠回肠和肝钠依赖性胆汁酸转运蛋白转运的影响”Biosci.Biochem.66(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kato N and Iwami K.: "Resistant protein ; its existence and function beneficial to health"J Nutr Sci Vitaminol.. 48. 1-5 (2002)
Kato N 和 Iwami K.:“抵抗蛋白;其存在和功能有益于健康”J Nutr Sci Vitaminol.. 48. 1-5 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Saeki T et al.: "Characterization of cloned mouse Na^+/taurocholate cotransporting ; polypeptide by transient expression in COS-7 cells"Biosci Biotech Biochem.. 66. 1116-1118 (2002)
Saeki T 等人:“通过在 COS-7 细胞中瞬时表达来表征克隆小鼠 Na+/牛磺胆酸盐共转运;多肽”Biosci Biotech Biochem.. 66. 1116-1118 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IWAMI Kimikazu其他文献
IWAMI Kimikazu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IWAMI Kimikazu', 18)}}的其他基金
Site-oriented absorption function and its regulation mechanism
位点吸收功能及其调控机制
- 批准号:
06660163 - 财政年份:1994
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Nutritional Regulation of Intestinal Bile Acid Reabsorption
肠道胆汁酸重吸收的营养调节
- 批准号:
63560092 - 财政年份:1988
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Analysis of Colletotrichum higginsianum recognition system by a novel ankyrin repeat-containing resistant protein
通过新型锚蛋白重复序列抗性蛋白分析炭疽菌识别系统
- 批准号:
23K05159 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of pathogen effector recognition site of rice blast resistant protein
稻瘟病抗性蛋白病原效应子识别位点的功能分析
- 批准号:
21K20586 - 财政年份:2021
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Integrated OMICS Study of the Beneficial Effects of Egg Shell Membrane-derived Resistant Protein on Intestinal Bacteria
蛋壳膜衍生抗性蛋白对肠道细菌有益作用的综合组学研究
- 批准号:
20F20401 - 财政年份:2020
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Elucidation of pathogen recognition system mediated by bacterial wilt resistant protein
阐明青枯病抗性蛋白介导的病原体识别系统
- 批准号:
19K15847 - 财政年份:2019
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CHEMO-RESISTANT PROTEIN EXPRESSION PATTERN OF GLIOBLASTOMA CELLS (A172)
胶质母细胞瘤细胞的化疗耐药蛋白表达模式 (A172)
- 批准号:
8365798 - 财政年份:2011
- 资助金额:
$ 2.3万 - 项目类别:
Aldose Reductase-Like-1, a Novel Hepatocellular Carcinoma Drug Resistant Protein
醛糖还原酶样-1,一种新型肝细胞癌耐药蛋白
- 批准号:
7261164 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Aldose Reductase-Like-1, a Novel Hepatocellular Carcinoma Drug Resistant Protein
醛糖还原酶样-1,一种新型肝细胞癌耐药蛋白
- 批准号:
7487367 - 财政年份:2007
- 资助金额:
$ 2.3万 - 项目类别:
Development of anti-carcinogenic food by using soybean resistant protein
利用大豆抗性蛋白开发抗癌食品
- 批准号:
12660120 - 财政年份:2000
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PEPSIN RESISTANT PROTEIN: RELATION TO ACIDIC MATRIX MACROMOLECULES
胃蛋白酶抵抗蛋白:与酸性基质大分子的关系
- 批准号:
3909503 - 财政年份:
- 资助金额:
$ 2.3万 - 项目类别:
PURIFY & CHARACTERIZE 140KD PEPSIN-RESISTANT PROTEIN: ACID MATRIX MACROMOLECULE
净化
- 批准号:
3953264 - 财政年份:
- 资助金额:
$ 2.3万 - 项目类别: